Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122120) titled 'Efficacy and Safety of Oliceridine for Preventing Puncture Pain During Nerve Block in Elderly Patients' on April 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Lu'an People's Hospital of Anhui Province
Condition:
Nerve block puncture pain
Intervention:
Oliceridine Group:Intravenous administration of oliceridine at a dose of 0.02 mg/kg prior to the nerve block procedure.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-08-29
Target Sample Size: Oliceridine Group:100;Sufentanil Group:100;
Countries of Recruitment:
China
To know more, visit h...